ArticleAlzheimer's research & therapy2025

Higher phosphorylated tau levels predict cognitive decline and amyloid-related imaging abnormalities during lecanemab treatment: clinical practice data.

Moeko Noguchi-Shinohara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.